First Fatal Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Case in an Adult in Korea
暂无分享,去创建一个
S. Park | Kyung-Hwa Park | H. Jang | Seung-Jung Kee | Sook-In Jung | Yong-Soo Kwon | Seung-Ji Kang | S. Hong
[1] Alicia M. Fry,et al. Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus Infections, United States, 2010–11 , 2012, Emerging infectious diseases.
[2] M. Boeckh,et al. H275Y Mutant Pandemic (H1N1) 2009 Virus in Immunocompromised Patients , 2011, Emerging infectious diseases.
[3] Mi-Seon Kim,et al. Oseltamivir-Resistant Pandemic (H1N1) 2009 Virus, South Korea , 2010, Emerging infectious diseases.
[4] C. Wolfe,et al. Pandemic (H1N1) 2009 and Oseltamivir Resistance in Hematology/Oncology Patients , 2010, Emerging infectious diseases.
[5] R. Webster,et al. Oseltamivir–Resistant Pandemic H1N1/2009 Influenza Virus Possesses Lower Transmissibility and Fitness in Ferrets , 2010, PLoS pathogens.
[6] G. Boivin,et al. Effect of the neuraminidase mutation H274Y conferring resistance to oseltamivir on the replicative capacity and virulence of old and recent human influenza A(H1N1) viruses. , 2010, The Journal of infectious diseases.
[7] Young Keun Kim,et al. A Case of Oseltamivir-Resistant Pandemic Influenza (H1N1 2009) in a Patient with Acute Myeloid Leukemia , 2009 .
[8] H. Hong,et al. A Case of Oseltamivir-Resistant Pandemic Influenza (H1N1 2009) , 2009 .
[9] E. van der Vries,et al. Fatal oseltamivir-resistant influenza virus infection. , 2008, The New England journal of medicine.
[10] J. Oxford,et al. The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo. , 2002, Antiviral research.